SCHEMBL2198944

SCHEMBL2198944

Cc1cc(OCCOC2CCCCO2)ccc1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
KDM4C Q9H3R0 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.40
VCP P55072 1/20 0.37
CHEK1 O14757 1/20 0.37
MAPK1 P28482 2/20 0.36
HBB P68871 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PDIA6 Q15084 1/20 0.35
MAPT P10636 1/20 0.35
MAOB P27338 1/20 0.35
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
LMNA P02545 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
STAT3 P40763 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198305 0.94 MEN1 (0.54) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL22597190 0.94 MEN1 (0.57) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL16659429 0.88 MEN1 (0.49) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL578407 0.85 MEN1 (0.49) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL14228856 0.82 KMT2A (0.57) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL7263741 0.81 MEN1 (0.59) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL3451372 0.81 HSD11B1 (0.43) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL171304 0.81 MEN1 (0.59) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL12409080 0.80 KDM4C (0.50) MEN1KMT2ANPC1RAB9AKDM4C
SCHEMBL4070838 0.80 MEN1 (0.51) MEN1KMT2ANPC1RAB9AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MEN1 1114/4885KMT2A 3430/4885NPC1 2170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.